EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ginsenoside Rb1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway

Ziwei Zhou, Zhimin Song, Xiaomeng Guo, Qi Wang, Meijing Li, Minyu Zhang, Muxin Gong

Pharmaceuticals · 30.03.2025 · 18 (4) · 500

DOI: 10.3390/ph18040500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 30.03.2025. Verfasst von Ziwei Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF), the terminal stage of cardiovascular disease with high morbidity and mortality, remains poorly managed by current therapies. Ventricular remodeling in HF is fundamentally characterized by myocardial fibrosis. While ginsenoside Rb1 has demonstrated anti-fibrotic effects in HF, the underlying mechanism remains unclear. Twist1, an upstream regulator of energy metabolism factors PGC-1α and PPARα, may attenuate fibrosis by preserving systemic energy homeostasis, suggesting its pivotal role in HF pathogenesis. This study explores ginsenoside Rb1′s anti-HF mechanisms through the regulation of ginsenoside Rb1 on these metabolic regulators.

Methods

Sprague Dawley rats were subjected to a ligation of the left anterior descending coronary artery to induce an HF model, followed by ginsenoside Rb1 treatment for 6 weeks. Therapeutic effects were evaluated through cardiac function assessment, myocardial histopathological staining (HE, Masson, immunofluorescence, immunohistochemistry), mitochondrial morphology observation (transmission electron microscopy), energy metabolism analysis (electron transport chain efficiency, mitochondrial membrane potential, ATP content), and protein expression profiling (Twist1, PGC-1α, PPARα, GLUT4, PPARγ). Additionally, H9c2 cells induced with endothelin-1 to model HF were employed as an in vitro model to further investigate ginsenoside Rb1′s regulatory effects on the Twist1/PGC-1α/PPARα signaling pathway.

Results

Ginsenoside Rb1 can restore cardiac function in HF rats, improve mitochondrial function, alleviate energy metabolism disorders, and inhibit ventricular remodeling. By modulating the Twist1/PGC-1α/PPARα signaling pathway, ginsenoside Rb1 suppressed the abnormal overexpression of Twist1 and maintained normal expression of downstream PGC-1α and PPARα. In vitro experiments further demonstrated that ginsenoside Rb1 significantly inhibited Twist1 expression in H9c2 cardiomyocytes with HF while promoting PGC-1α and PPARα expression, thereby restoring myocardial energy metabolism and mitigating ventricular remodeling in HF.

Conclusions

Ginsenoside Rb1 can inhibit the upregulation of Twist1 and activate the expression of its downstream PGC-1α and PPARα expression, by modulating the Twist1/PGC-1α/PPARα signaling pathway, alleviating ventricular remodeling in HF patients and improving myocardial energy metabolism dysfunction. Twist1 may be a key target for the treatment of HF. This study not only elucidates the mechanism by which ginsenoside Rb1 alleviates HF, but also provides new insights into the clinical treatment of HF.

Schlagwörter

Stichwörter der Autor:innen

Twist homolog 1 (Twist1)ginsenoside Rb1heart failuremyocardial energy metabolism disorder

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
  • Beijing Key Laboratory of Traditional Chinese Medicine Collateral Disease Theory Research, Beijing 100069, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, Z., Song, Z., Guo, X., Wang, Q., Li, M., Zhang, M., & Gong, M. (2025). Ginsenoside Rb1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway. Pharmaceuticals, 18(4), 500. https://doi.org/10.3390/ph18040500

Vancouver

Zhou Z, Song Z, Guo X, Wang Q, Li M, Zhang M, et al. Ginsenoside Rb1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway. Pharmaceuticals. 2025;18(4):500. doi:10.3390/ph18040500

BibTeX
@article{Zhou2025,
  author = {Zhou, Ziwei and Song, Zhimin and Guo, Xiaomeng and Wang, Qi and Li, Meijing and Zhang, Minyu and Gong, Muxin},
  title = {Ginsenoside Rb1 Ameliorates Heart Failure Ventricular Remodeling by Regulating the Twist1/PGC-1α/PPARα Signaling Pathway},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {4},
  pages = {500},
  doi = {10.3390/ph18040500}
}
Kostenlos starten →